1. Home
  2. BDSX vs AGD Comparison

BDSX vs AGD Comparison

Compare BDSX & AGD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BDSX
  • AGD
  • Stock Information
  • Founded
  • BDSX 2005
  • AGD 2006
  • Country
  • BDSX United States
  • AGD United Kingdom
  • Employees
  • BDSX N/A
  • AGD N/A
  • Industry
  • BDSX Precision Instruments
  • AGD Trusts Except Educational Religious and Charitable
  • Sector
  • BDSX Health Care
  • AGD Finance
  • Exchange
  • BDSX Nasdaq
  • AGD Nasdaq
  • Market Cap
  • BDSX 115.4M
  • AGD 263.6M
  • IPO Year
  • BDSX 2020
  • AGD N/A
  • Fundamental
  • Price
  • BDSX $0.28
  • AGD $11.24
  • Analyst Decision
  • BDSX Strong Buy
  • AGD
  • Analyst Count
  • BDSX 5
  • AGD 0
  • Target Price
  • BDSX $1.75
  • AGD N/A
  • AVG Volume (30 Days)
  • BDSX 1.8M
  • AGD 61.2K
  • Earning Date
  • BDSX 08-06-2025
  • AGD 01-01-0001
  • Dividend Yield
  • BDSX N/A
  • AGD 8.13%
  • EPS Growth
  • BDSX N/A
  • AGD N/A
  • EPS
  • BDSX N/A
  • AGD N/A
  • Revenue
  • BDSX $74,463,000.00
  • AGD N/A
  • Revenue This Year
  • BDSX $17.29
  • AGD N/A
  • Revenue Next Year
  • BDSX $29.33
  • AGD N/A
  • P/E Ratio
  • BDSX N/A
  • AGD N/A
  • Revenue Growth
  • BDSX 35.76
  • AGD N/A
  • 52 Week Low
  • BDSX $0.17
  • AGD $8.20
  • 52 Week High
  • BDSX $2.04
  • AGD $9.78
  • Technical
  • Relative Strength Index (RSI)
  • BDSX 43.14
  • AGD 77.86
  • Support Level
  • BDSX $0.27
  • AGD $10.34
  • Resistance Level
  • BDSX $0.31
  • AGD $11.21
  • Average True Range (ATR)
  • BDSX 0.02
  • AGD 0.11
  • MACD
  • BDSX 0.01
  • AGD 0.05
  • Stochastic Oscillator
  • BDSX 45.45
  • AGD 98.28

About BDSX Biodesix Inc.

Biodesix Inc is a diagnostic solutions company with a focus in lung disease. The Company has a single operating segment focused on providing diagnostic testing services to customers. It provides biopharmaceutical companies with services that include diagnostic research, clinical trial testing, and the discovery, development, and commercialization of companion diagnostics. The revenue is derived from two sources, providing diagnostic testing services associated with blood-based lung and Coronavirus Disease 2019 (COVID-19) tests; and providing biopharmaceutical companies with services generally provided outside the clinical setting and governed by individual contracts with third parties as well as development and commercialization of companion diagnostics.

About AGD abrdn Global Dynamic Dividend Fund of Beneficial Interest

Aberdeen Global Dynamic Dividend Fund is a diversified, closed-end management investment company. The fund's primary investment objective is to seek high current dividend income, more than 50% of which qualifies for the reduced federal income tax rate, as created by the Jobs and Growth Tax Relief Reconciliation Act of 2003. The fund also focuses on the long-term growth of capital as a secondary investment objective. The fund's portfolio holdings are in information technology, financials, health care, and consumer discretionary sectors among others.

Share on Social Networks: